Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02675829 |
|---|---|
| Brief Title: | Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers |
| First Submitted : | February 3, 2016 |
| First Submitted that Met QC Criteria : | February 3, 2016 |
| First Posted : | February 5, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 7, 2022 |
| Last Update Posted : | September 8, 2022 |